{"id":"https://genegraph.clinicalgenome.org/r/ccba5199-7ef0-4beb-9f58-8817f935c12ev1.0","type":"EvidenceStrengthAssertion","dc:description":"After a comprehensive literature review, the gene-disease relationship between BMPR1A and pulmonary arterial hypertension is disputed. Despite experimental evidence including function in biochemical pathways, protein interaction with BMPR2, and expression evidence in pulmonary artery smooth muscle cells, there is insufficient proband level genetic evidence to classify the relationship as limited. Instead, a classification of disputed was reached due to insufficient proband level evidence over multiple years. Classification approved by Pulmonary Hypertension GCEP panal on 8/30/22. ","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/ccba5199-7ef0-4beb-9f58-8817f935c12e","GCISnapshot":"https://genegraph.clinicalgenome.org/r/e810879d-f635-4851-b20e-86998b000fcc","calculatedEvidenceStrength":"NoKnownDiseaseRelationship","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/e810879d-f635-4851-b20e-86998b000fcc_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10071","date":"2022-10-18T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/e810879d-f635-4851-b20e-86998b000fcc_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10071","date":"2022-10-18T16:01:20.263Z","role":"Publisher"}],"curationReasonDescription":"Due to a lack of proband level genetic evidence over multiple years of investigative studies, this gene is classified as disputed.","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e810879d-f635-4851-b20e-86998b000fcc_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e810879d-f635-4851-b20e-86998b000fcc_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d4317bd7-6bc8-4169-8b90-5673dc2a4547","type":"EvidenceLine","dc:description":"The function of BMPR type 1 receptors and their role in signal transduction via interaction with BMPR type 2 receptors and Smad proteins has been well characterized and studied. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/169b3688-2210-486b-b346-2a47557244c8","type":"Finding","dc:description":"BMP proteins are essential for the development of various embryonic tissue and TGFÎ² signaling is implicated in a number of biological processes including cell fate decisions, tissue patterning, and cell proliferation, death and differentiation. BMPR type 2 is definitively associated with PAH. According to this review article, BMPR type 2 activates Smad proteins and transcription via its ability to phosphorylate BMPR type 1 receptors. ","dc:source":"https://pubmed.ncbi.nlm.nih.gov/16340955","rdfs:label":"Liu review of BMP signaling ","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/a90ba641-4073-4a95-8a48-0f6f20022a22","type":"EvidenceLine","dc:description":"The interaction between BMPR1A and BMPR2 has been well characterized by multiple research papers, demonstrating that BMPR2 activity is mediated through BMPR1A phosphorylation. ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc272fd3-a45e-4075-a7b7-110438734e98","type":"Finding","dc:description":"The interaction between BMPR1A and BMPR2 has been well characterized. Nohe and colleagues demonstrated in an immunoprecipitation assay that BMPR1A and BMPR2 coprecipitated together, but that truncated versions of BMPR2 could not associate with all domains of BMPR1A. Additionally, the authors found that the ability of BMPR2 kinase receptor mutants to inhibit BMP signaling depended on their ability to form heteromeric complexes with BMPR1A. Further review articles, such as (PMID:16340955), have demonstrated that BMPR2 receptor activity functions by phosphorylating BMPR1A. BMPR2 is definitively associated with Pulmonary Arterial Hypertension.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/11714695","rdfs:label":"Nohe interaction between BMPR1A and BMPR2","demonstrates":{"id":"obo:MI_0915"}}],"specifiedBy":"GeneValidityProteinInteractionCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/55906689-2763-40ec-b422-77bde57a3bd5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5d029290-c462-443b-8e4d-1dc8242f3ced","type":"Finding","dc:description":"Expression of both BMPR1A (ALK3) and BMPR1B (ALK6) in pulmonary artery smooth muscle cells but not pulmonary artery epithelial cells by semiquantitative RT-PCR. In hereditary PAH caused by BMPR2 mutations, pulmonary artery smooth muscle cells are linked to the disease by contributing to abnormal growth responses following BMP signaling (PMID: 32850144).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17989347","rdfs:label":"Upton Expression of BMPR1A ","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/e810879d-f635-4851-b20e-86998b000fcc_overall_genetic_evidence_line","type":"EvidenceLine","specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":0}],"evidenceStrength":"Disputed","sequence":5255,"specifiedBy":"GeneValidityCriteria9","strengthScore":2,"subject":{"id":"https://genegraph.clinicalgenome.org/r/V7s9CeznUaw","type":"GeneValidityProposition","disease":"obo:MONDO_0015924","gene":"hgnc:1076","modeOfInheritance":"obo:HP_0000005"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_e810879d-f635-4851-b20e-86998b000fcc-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}